Literature DB >> 9792341

Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.

X G Fan1, W E Liu, C Z Li, Z C Wang, L X Luo, D M Tan, G L Hu, Z Zhang.   

Abstract

The imbalance of T-helper (Th) lymphocyte cytokine production may play an important role in immunopathogenesis of persistent hepatitis C virus (HCV) infection. To know whether an imbalance between Th1 and Th2 cytokines is present in chronic HCV infection, serum levels of Th1 cytokines, interferon gamma (IFN-gamma) and interleukin (IL)-2, and Th2 cytokines, IL-4 and IL-10, were measured using enzyme-linked immunosorbent assay in this study. Eighteen individuals with chronic HCV infection, 11 healthy subjects as normal controls and 10 chronic HBV infected patients as disease controls were observed. The results showed that the levels of Th2 cytokines (IL-4 and IL-10) were significantly increased in chronic HCV infected patients compared with normal controls (IL-4: 30.49+/-17.55 vs. 14.94+/-13.73, pg/ml, P<0.025; IL-10: 50.30+/-19.59 vs. 17.87+/-9.49, pg/ml, P<0.001). Similarly, the levels of Th1 cytokine, IL-2, was also elevated in individuals with chronic HCV infection when compared with normal controls (IL-2: 118.53+/-95.23 vs. 61.57+/-28.70, pg/ml, P<0.05). However, Th1 cytokine IFN-gamma level was not significantly changed during HCV infection (IFN-gamma: 28.09+/-15.65 vs. 24.10+/-15.61, pg/ml, P>0.05). Furthermore, the elevated levels of Th2 cytokines are greater than Th1 cytokines in HCV infection. Thus, the study indicates that an enhanced Th2 responses are present during chronic HCV infection, which may partly be responsible for the persistence of HCV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792341      PMCID: PMC1781851          DOI: 10.1080/09629359890992

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  12 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 2.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

3.  Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Gibo; K Yoshizawa; Y Nakano; S Furuta; Y Akahane; K Nishioka; R H Purcell
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

Review 4.  Enhanced T-helper 2 lymphocyte responses: immune mechanism of Helicobacter pylori infection.

Authors:  X G Fan; J Yakoob; X J Fan; P W Keeling
Journal:  Ir J Med Sci       Date:  1996 Jan-Mar       Impact factor: 1.568

5.  Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

Authors:  A Bertoletti; M M D'Elios; C Boni; M De Carli; A L Zignego; M Durazzo; G Missale; A Penna; F Fiaccadori; G Del Prete; C Ferrari
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

6.  Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.

Authors:  R M Hoffmann; H M Diepolder; R Zachoval; F M Zwiebel; M C Jung; S Scholz; H Nitschko; G Riethmüller; G R Pape
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

7.  Effect of IL-4 on peripheral blood lymphocyte proliferation: implication in immunopathogenesis of H. pylori infection.

Authors:  X G Fan; J Yakoob; X J Fan; P W Keeling
Journal:  Immunol Lett       Date:  1995-11       Impact factor: 3.685

8.  Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection.

Authors:  K Iwata; T Wakita; A Okumura; K Yoshioka; M Takayanagi; J R Wands; S Kakumu
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

9.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.

Authors:  A J Weiner; H M Geysen; C Christopherson; J E Hall; T J Mason; G Saracco; F Bonino; K Crawford; C D Marion; K A Crawford
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

10.  Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus.

Authors:  S L Tsai; Y F Liaw; C T Yeh; C M Chu; G C Kuo
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

View more
  32 in total

Review 1.  Review of cytokine profiles in patients with hepatitis.

Authors:  Qiao-Ling Sun; Wei Ran
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

2.  The long way toward understanding host and viral determinants of therapeutic success in HCV infection.

Authors:  Pierre-Alain Rubbo; Philippe Van de Perre; Edouard Tuaillon
Journal:  Hepatol Int       Date:  2012-01-14       Impact factor: 6.047

3.  Lack of evidence for the Th2 predominance in patients with chronic hepatitis C.

Authors:  A Bergamini; F Bolacchi; G Cerasari; C Carvelli; E Faggioli; M Cepparulo; F Demin; I Uccella; B Bongiovanni; P Niutta; M Capozzi; M Lupi; E Piscitelli; G Rocchi; M Angelico
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

4.  Intracellular cytokine analysis of CD4-positive T cells predictive of sustained response to interferon therapy for patients with chronic hepatitis C.

Authors:  K Ishii; N Takamura; E Shinohara; H Y Shin; T Ikehara; S Hata; T Kawafune; Y Sumino; Y Ohmoto
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

5.  Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders.

Authors:  Luigi Buonaguro; Annacarmen Petrizzo; Marialina Tornesello; Maria Napolitano; Debora Martorelli; Giuseppe Castello; Gerardo Beneduce; Amalia De Renzo; Oreste Perrella; Luca Romagnoli; Vitor Sousa; Valli De Re; Riccardo Dolcetti; Franco M Buonaguro
Journal:  J Transl Med       Date:  2010-02-19       Impact factor: 5.531

6.  Role of activation-induced cell death in pathogenesis of patients with chronic hepatitis B.

Authors:  Chun-Sheng Hou; Gui-Qiang Wang; Shu-Lan Lu; Bei Yue; Ming-Rong Li; Xiao-Yan Wang; Jian-Wu Yu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 8.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

9.  IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

10.  Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.

Authors:  Abdel-Rahman N Zekri; Hanaa M Alam El-Din; Abeer A Bahnassy; Naglaa A Zayed; Waleed S Mohamed; Suzan H El-Masry; Sayed K Gouda; Gamal Esmat
Journal:  Comp Hepatol       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.